APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vendor Neutral Archive (VNA) & PACS

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Vendor Neutral Archive (VNA) & PACS Market Outlook and Growth Opportunities 2026

3 May 2026193 pages

Choose your research edition.

Industry ResearchVendor Neutral Archive (VNA) & PACS Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Vendor Neutral Archive (VNA) & PACS Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Vendor Neutral Archive (VNA) & PACS Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vendor Neutral Archive (VNA) & PACS Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Vendor Neutral Archive (VNA) & PACS Market Analysis and Forecast 2026-2032232 pages · $4,950 USD

Market perspective

The global Vendor Neutral Archive (VNA) & PACS market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Vendor Neutral Archive (VNA) & PACS is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Vendor Neutral Archive (VNA) & PACS is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Vendor Neutral Archive (VNA) & PACS is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Vendor Neutral Archive (VNA) & PACS market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Vendor Neutral Archive (VNA) & PACS market include GE Healthcare Technologies Inc., Siemens Healthcare Limited, Canon Medical Systems Corporation, FUJIFILM Holdings Corporation, Agfa-Gevaert Group, Sectra AB, Hyland Software, Inc., Intelerad Medical Systems Inc and Merative, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Vendor Neutral Archive (VNA) & PACS market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Vendor Neutral Archive (VNA) & PACS and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Vendor Neutral Archive (VNA) & PACS revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Vendor Neutral Archive (VNA) & PACS market.

Vendor Neutral Archive (VNA) & PACS Segment by Company

GE Healthcare Technologies Inc.

Siemens Healthcare Limited

Canon Medical Systems Corporation

FUJIFILM Holdings Corporation

Agfa-Gevaert Group

Sectra AB

Hyland Software, Inc.

Intelerad Medical Systems Inc

Merative

Novarad Corporation

Esaote SPA

Dedalus s.p.A.

BridgeHead Software Ltd.

PaxeraHealth

Medicasoft

Visus Health IT GmbH

POSTDICOM

Vendor Neutral Archive (VNA) & PACS Segment by Type

CT

MRl

X-rays

Ultrasound

Mammo

PET

Vendor Neutral Archive (VNA) & PACS Segment by Application

Hospital

Surgery Center

Other

Vendor Neutral Archive (VNA) & PACS Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Vendor Neutral Archive (VNA) & PACS status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Vendor Neutral Archive (VNA) & PACS key companies, revenue, market share, and recent developments.

3. To split the Vendor Neutral Archive (VNA) & PACS breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Vendor Neutral Archive (VNA) & PACS market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Vendor Neutral Archive (VNA) & PACS significant trends, drivers, influence factors in global and regions.

6. To analyze Vendor Neutral Archive (VNA) & PACS competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vendor Neutral Archive (VNA) & PACS market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vendor Neutral Archive (VNA) & PACS and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vendor Neutral Archive (VNA) & PACS.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Vendor Neutral Archive (VNA) & PACS industry.

Chapter 3: Detailed analysis of Vendor Neutral Archive (VNA) & PACS company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Vendor Neutral Archive (VNA) & PACS in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Vendor Neutral Archive (VNA) & PACS in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Vendor Neutral Archive (VNA) & PACS Industry Trends Table 2. Vendor Neutral Archive (VNA) & PACS Industry Drivers Table 3. Vendor Neutral Archive (VNA) & PACS Industry Opportunities and Challenges Table 4. Vendor Neutral Archive (VNA) & PACS Industry Restraints Table 5. Global Vendor Neutral Archive (VNA) & PACS Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Vendor Neutral Archive (VNA) & PACS Revenue Share by Company (2021-2026) Table 7. Global Vendor Neutral Archive (VNA) & PACS Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Vendor Neutral Archive (VNA) & PACS Key Company Manufacturing Base & Headquarters Table 9. Global Vendor Neutral Archive (VNA) & PACS Company, Product Type & Application Table 10. Global Vendor Neutral Archive (VNA) & PACS Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Vendor Neutral Archive (VNA) & PACS by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of CT Table 15. Significant Companies of MRl Table 16. Significant Companies of X-rays Table 17. Significant Companies of Ultrasound Table 18. Significant Companies of Mammo Table 19. Significant Companies of PET Table 20. Global Vendor Neutral Archive (VNA) & PACS Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 21. Global Vendor Neutral Archive (VNA) & PACS Sales Value by Type (2021-2026) & (US$ Million) Table 22. Global Vendor Neutral Archive (VNA) & PACS Sales Value by Type (2027-2032) & (US$ Million) Table 23. Global Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type (2021-2026) Table 24. Global Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type (2027-2032) Table 25. Significant Companies of Hospital Table 26. Significant Companies of Surgery Center Table 27. Significant Companies of Other Table 28. Global Vendor Neutral Archive (VNA) & PACS Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Vendor Neutral Archive (VNA) & PACS Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Vendor Neutral Archive (VNA) & PACS Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application (2021-2026) Table 32. Global Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application (2027-2032) Table 33. Global Vendor Neutral Archive (VNA) & PACS Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Vendor Neutral Archive (VNA) & PACS Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Vendor Neutral Archive (VNA) & PACS Sales Value Share by Region (2021-2026) Table 36. Global Vendor Neutral Archive (VNA) & PACS Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Vendor Neutral Archive (VNA) & PACS Sales Value Share by Region (2027-2032) Table 38. Global Vendor Neutral Archive (VNA) & PACS Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Vendor Neutral Archive (VNA) & PACS Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Vendor Neutral Archive (VNA) & PACS Sales Value Market Share by Country (2021-2026) Table 41. Global Vendor Neutral Archive (VNA) & PACS Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Vendor Neutral Archive (VNA) & PACS Sales Value Market Share by Country (2027-2032) Table 43. GE Healthcare Technologies Inc. Company Information Table 44. GE Healthcare Technologies Inc. Business Overview Table 45. GE Healthcare Technologies Inc. Vendor Neutral Archive (VNA) & PACS Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. GE Healthcare Technologies Inc. Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 47. GE Healthcare Technologies Inc. Recent Development Table 48. Siemens Healthcare Limited Company Information Table 49. Siemens Healthcare Limited Business Overview Table 50. Siemens Healthcare Limited Vendor Neutral Archive (VNA) & PACS Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Siemens Healthcare Limited Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 52. Siemens Healthcare Limited Recent Development Table 53. Canon Medical Systems Corporation Company Information Table 54. Canon Medical Systems Corporation Business Overview Table 55. Canon Medical Systems Corporation Vendor Neutral Archive (VNA) & PACS Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Canon Medical Systems Corporation Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 57. Canon Medical Systems Corporation Recent Development Table 58. FUJIFILM Holdings Corporation Company Information Table 59. FUJIFILM Holdings Corporation Business Overview Table 60. FUJIFILM Holdings Corporation Vendor Neutral Archive (VNA) & PACS Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. FUJIFILM Holdings Corporation Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 62. FUJIFILM Holdings Corporation Recent Development Table 63. Agfa-Gevaert Group Company Information Table 64. Agfa-Gevaert Group Business Overview Table 65. Agfa-Gevaert Group Vendor Neutral Archive (VNA) & PACS Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Agfa-Gevaert Group Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 67. Agfa-Gevaert Group Recent Development Table 68. Sectra AB Company Information Table 69. Sectra AB Business Overview Table 70. Sectra AB Vendor Neutral Archive (VNA) & PACS Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Sectra AB Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 72. Sectra AB Recent Development Table 73. Hyland Software, Inc. Company Information Table 74. Hyland Software, Inc. Business Overview Table 75. Hyland Software, Inc. Vendor Neutral Archive (VNA) & PACS Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Hyland Software, Inc. Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 77. Hyland Software, Inc. Recent Development Table 78. Intelerad Medical Systems Inc Company Information Table 79. Intelerad Medical Systems Inc Business Overview Table 80. Intelerad Medical Systems Inc Vendor Neutral Archive (VNA) & PACS Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Intelerad Medical Systems Inc Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 82. Intelerad Medical Systems Inc Recent Development Table 83. Merative Company Information Table 84. Merative Business Overview Table 85. Merative Vendor Neutral Archive (VNA) & PACS Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Merative Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 87. Merative Recent Development Table 88. Novarad Corporation Company Information Table 89. Novarad Corporation Business Overview Table 90. Novarad Corporation Vendor Neutral Archive (VNA) & PACS Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Novarad Corporation Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 92. Novarad Corporation Recent Development Table 93. Esaote SPA Company Information Table 94. Esaote SPA Business Overview Table 95. Esaote SPA Vendor Neutral Archive (VNA) & PACS Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Esaote SPA Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 97. Esaote SPA Recent Development Table 98. Dedalus s.p.A. Company Information Table 99. Dedalus s.p.A. Business Overview Table 100. Dedalus s.p.A. Vendor Neutral Archive (VNA) & PACS Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Dedalus s.p.A. Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 102. Dedalus s.p.A. Recent Development Table 103. BridgeHead Software Ltd. Company Information Table 104. BridgeHead Software Ltd. Business Overview Table 105. BridgeHead Software Ltd. Vendor Neutral Archive (VNA) & PACS Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. BridgeHead Software Ltd. Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 107. BridgeHead Software Ltd. Recent Development Table 108. PaxeraHealth Company Information Table 109. PaxeraHealth Business Overview Table 110. PaxeraHealth Vendor Neutral Archive (VNA) & PACS Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. PaxeraHealth Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 112. PaxeraHealth Recent Development Table 113. Medicasoft Company Information Table 114. Medicasoft Business Overview Table 115. Medicasoft Vendor Neutral Archive (VNA) & PACS Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Medicasoft Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 117. Medicasoft Recent Development Table 118. Visus Health IT GmbH Company Information Table 119. Visus Health IT GmbH Business Overview Table 120. Visus Health IT GmbH Vendor Neutral Archive (VNA) & PACS Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Visus Health IT GmbH Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 122. Visus Health IT GmbH Recent Development Table 123. POSTDICOM Company Information Table 124. POSTDICOM Business Overview Table 125. POSTDICOM Vendor Neutral Archive (VNA) & PACS Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. POSTDICOM Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 127. POSTDICOM Recent Development Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Vendor Neutral Archive (VNA) & PACS Product Image Figure 2. Global Vendor Neutral Archive (VNA) & PACS Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vendor Neutral Archive (VNA) & PACS Market Size (2021-2032) & (US$ Million) Figure 4. Global Vendor Neutral Archive (VNA) & PACS Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. CT Image Figure 8. MRl Image Figure 9. X-rays Image Figure 10. Ultrasound Image Figure 11. Mammo Image Figure 12. PET Image Figure 13. Global Vendor Neutral Archive (VNA) & PACS Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 14. Global Vendor Neutral Archive (VNA) & PACS Sales Value Share 2021 VS 2025 VS 2032 Figure 15. Global Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Surgery Center Image Figure 18. Other Image Figure 19. Global Vendor Neutral Archive (VNA) & PACS Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Vendor Neutral Archive (VNA) & PACS Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application (2021-2032) Figure 22. Global Vendor Neutral Archive (VNA) & PACS Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Vendor Neutral Archive (VNA) & PACS Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Vendor Neutral Archive (VNA) & PACS Sales Value (2021-2032) & (US$ Million) Figure 25. North America Vendor Neutral Archive (VNA) & PACS Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Vendor Neutral Archive (VNA) & PACS Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Vendor Neutral Archive (VNA) & PACS Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Vendor Neutral Archive (VNA) & PACS Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Vendor Neutral Archive (VNA) & PACS Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Vendor Neutral Archive (VNA) & PACS Sales Value (2021-2032) & (US$ Million) Figure 31. South America Vendor Neutral Archive (VNA) & PACS Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Vendor Neutral Archive (VNA) & PACS Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Vendor Neutral Archive (VNA) & PACS Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • CT
  • MRl
  • X-rays
  • Ultrasound
  • Mammo
  • PET
Applications
  • Hospital
  • Surgery Center
  • Other
Companies covered
  • GE Healthcare Technologies Inc.
  • Siemens Healthcare Limited
  • Canon Medical Systems Corporation
  • FUJIFILM Holdings Corporation
  • Agfa-Gevaert Group
  • Sectra AB
  • Hyland Software, Inc.
  • Intelerad Medical Systems Inc
  • Merative
  • Novarad Corporation
  • Esaote SPA
  • Dedalus s.p.A.
  • BridgeHead Software Ltd.
  • PaxeraHealth
  • Medicasoft
  • Visus Health IT GmbH
  • POSTDICOM

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Vendor Neutral Archive (VNA) & PACS Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Vendor Neutral Archive (VNA) & PACS Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Vendor Neutral Archive (VNA) & PACS Market Dynamics
  1. 2.1 Vendor Neutral Archive (VNA) & PACS Industry Trends
  2. 2.2 Vendor Neutral Archive (VNA) & PACS Industry Drivers
  3. 2.3 Vendor Neutral Archive (VNA) & PACS Industry Opportunities and Challenges
  4. 2.4 Vendor Neutral Archive (VNA) & PACS Industry Restraints
3 Vendor Neutral Archive (VNA) & PACS Market by Company
  1. 3.1 Global Vendor Neutral Archive (VNA) & PACS Company Revenue Ranking in 2025
  2. 3.2 Global Vendor Neutral Archive (VNA) & PACS Revenue by Company (2021-2026)
  3. 3.3 Global Vendor Neutral Archive (VNA) & PACS Company Ranking (2024-2026)
  4. 3.4 Global Vendor Neutral Archive (VNA) & PACS Company Manufacturing Base and Headquarters
  5. 3.5 Global Vendor Neutral Archive (VNA) & PACS Company Product Type and Application
  6. 3.6 Global Vendor Neutral Archive (VNA) & PACS Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Vendor Neutral Archive (VNA) & PACS Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Vendor Neutral Archive (VNA) & PACS Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Vendor Neutral Archive (VNA) & PACS Market by Type
  1. 4.1 Vendor Neutral Archive (VNA) & PACS Type Introduction
  2. 4.1.1 CT
  3. 4.1.2 MRl
  4. 4.1.3 X-rays
  5. 4.1.4 Ultrasound
  6. 4.1.5 Mammo
  7. 4.1.6 PET
  8. 4.2 Global Vendor Neutral Archive (VNA) & PACS Sales Value by Type
  9. 4.2.1 Global Vendor Neutral Archive (VNA) & PACS Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Vendor Neutral Archive (VNA) & PACS Sales Value by Type (2021-2032)
  11. 4.2.3 Global Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type (2021-2032)
5 Vendor Neutral Archive (VNA) & PACS Market by Application
  1. 5.1 Vendor Neutral Archive (VNA) & PACS Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Surgery Center
  4. 5.1.3 Other
  5. 5.2 Global Vendor Neutral Archive (VNA) & PACS Sales Value by Application
  6. 5.2.1 Global Vendor Neutral Archive (VNA) & PACS Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Vendor Neutral Archive (VNA) & PACS Sales Value by Application (2021-2032)
  8. 5.2.3 Global Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application (2021-2032)
6 Vendor Neutral Archive (VNA) & PACS Regional Value Analysis
  1. 6.1 Global Vendor Neutral Archive (VNA) & PACS Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Vendor Neutral Archive (VNA) & PACS Sales Value by Region (2021-2032)
  3. 6.2.1 Global Vendor Neutral Archive (VNA) & PACS Sales Value by Region: 2021-2026
  4. 6.2.2 Global Vendor Neutral Archive (VNA) & PACS Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Vendor Neutral Archive (VNA) & PACS Sales Value (2021-2032)
  7. 6.3.2 North America Vendor Neutral Archive (VNA) & PACS Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Vendor Neutral Archive (VNA) & PACS Sales Value (2021-2032)
  10. 6.4.2 Europe Vendor Neutral Archive (VNA) & PACS Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Vendor Neutral Archive (VNA) & PACS Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Vendor Neutral Archive (VNA) & PACS Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Vendor Neutral Archive (VNA) & PACS Sales Value (2021-2032)
  16. 6.6.2 South America Vendor Neutral Archive (VNA) & PACS Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Vendor Neutral Archive (VNA) & PACS Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Vendor Neutral Archive (VNA) & PACS Sales Value Share by Country, 2025 VS 2032
7 Vendor Neutral Archive (VNA) & PACS Country-level Value Analysis
  1. 7.1 Global Vendor Neutral Archive (VNA) & PACS Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Vendor Neutral Archive (VNA) & PACS Sales Value by Country (2021-2032)
  3. 7.2.1 Global Vendor Neutral Archive (VNA) & PACS Sales Value by Country (2021-2026)
  4. 7.2.2 Global Vendor Neutral Archive (VNA) & PACS Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Vendor Neutral Archive (VNA) & PACS Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Vendor Neutral Archive (VNA) & PACS Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Vendor Neutral Archive (VNA) & PACS Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 GE Healthcare Technologies Inc.
  2. 8.1.1 GE Healthcare Technologies Inc. Company Information
  3. 8.1.2 GE Healthcare Technologies Inc. Business Overview
  4. 8.1.3 GE Healthcare Technologies Inc. Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (2021-2026)
  5. 8.1.4 GE Healthcare Technologies Inc. Vendor Neutral Archive (VNA) & PACS Product Portfolio
  6. 8.1.5 GE Healthcare Technologies Inc. Recent Developments
  7. 8.2 Siemens Healthcare Limited
  8. 8.2.1 Siemens Healthcare Limited Company Information
  9. 8.2.2 Siemens Healthcare Limited Business Overview
  10. 8.2.3 Siemens Healthcare Limited Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Siemens Healthcare Limited Vendor Neutral Archive (VNA) & PACS Product Portfolio
  12. 8.2.5 Siemens Healthcare Limited Recent Developments
  13. 8.3 Canon Medical Systems Corporation
  14. 8.3.1 Canon Medical Systems Corporation Company Information
  15. 8.3.2 Canon Medical Systems Corporation Business Overview
  16. 8.3.3 Canon Medical Systems Corporation Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Canon Medical Systems Corporation Vendor Neutral Archive (VNA) & PACS Product Portfolio
  18. 8.3.5 Canon Medical Systems Corporation Recent Developments
  19. 8.4 FUJIFILM Holdings Corporation
  20. 8.4.1 FUJIFILM Holdings Corporation Company Information
  21. 8.4.2 FUJIFILM Holdings Corporation Business Overview
  22. 8.4.3 FUJIFILM Holdings Corporation Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (2021-2026)
  23. 8.4.4 FUJIFILM Holdings Corporation Vendor Neutral Archive (VNA) & PACS Product Portfolio
  24. 8.4.5 FUJIFILM Holdings Corporation Recent Developments
  25. 8.5 Agfa-Gevaert Group
  26. 8.5.1 Agfa-Gevaert Group Company Information
  27. 8.5.2 Agfa-Gevaert Group Business Overview
  28. 8.5.3 Agfa-Gevaert Group Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Agfa-Gevaert Group Vendor Neutral Archive (VNA) & PACS Product Portfolio
  30. 8.5.5 Agfa-Gevaert Group Recent Developments
  31. 8.6 Sectra AB
  32. 8.6.1 Sectra AB Company Information
  33. 8.6.2 Sectra AB Business Overview
  34. 8.6.3 Sectra AB Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sectra AB Vendor Neutral Archive (VNA) & PACS Product Portfolio
  36. 8.6.5 Sectra AB Recent Developments
  37. 8.7 Hyland Software, Inc.
  38. 8.7.1 Hyland Software, Inc. Company Information
  39. 8.7.2 Hyland Software, Inc. Business Overview
  40. 8.7.3 Hyland Software, Inc. Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Hyland Software, Inc. Vendor Neutral Archive (VNA) & PACS Product Portfolio
  42. 8.7.5 Hyland Software, Inc. Recent Developments
  43. 8.8 Intelerad Medical Systems Inc
  44. 8.8.1 Intelerad Medical Systems Inc Company Information
  45. 8.8.2 Intelerad Medical Systems Inc Business Overview
  46. 8.8.3 Intelerad Medical Systems Inc Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Intelerad Medical Systems Inc Vendor Neutral Archive (VNA) & PACS Product Portfolio
  48. 8.8.5 Intelerad Medical Systems Inc Recent Developments
  49. 8.9 Merative
  50. 8.9.1 Merative Company Information
  51. 8.9.2 Merative Business Overview
  52. 8.9.3 Merative Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Merative Vendor Neutral Archive (VNA) & PACS Product Portfolio
  54. 8.9.5 Merative Recent Developments
  55. 8.10 Novarad Corporation
  56. 8.10.1 Novarad Corporation Company Information
  57. 8.10.2 Novarad Corporation Business Overview
  58. 8.10.3 Novarad Corporation Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Novarad Corporation Vendor Neutral Archive (VNA) & PACS Product Portfolio
  60. 8.10.5 Novarad Corporation Recent Developments
  61. 8.11 Esaote SPA
  62. 8.11.1 Esaote SPA Company Information
  63. 8.11.2 Esaote SPA Business Overview
  64. 8.11.3 Esaote SPA Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Esaote SPA Vendor Neutral Archive (VNA) & PACS Product Portfolio
  66. 8.11.5 Esaote SPA Recent Developments
  67. 8.12 Dedalus s.p.A.
  68. 8.12.1 Dedalus s.p.A. Company Information
  69. 8.12.2 Dedalus s.p.A. Business Overview
  70. 8.12.3 Dedalus s.p.A. Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Dedalus s.p.A. Vendor Neutral Archive (VNA) & PACS Product Portfolio
  72. 8.12.5 Dedalus s.p.A. Recent Developments
  73. 8.13 BridgeHead Software Ltd.
  74. 8.13.1 BridgeHead Software Ltd. Company Information
  75. 8.13.2 BridgeHead Software Ltd. Business Overview
  76. 8.13.3 BridgeHead Software Ltd. Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (2021-2026)
  77. 8.13.4 BridgeHead Software Ltd. Vendor Neutral Archive (VNA) & PACS Product Portfolio
  78. 8.13.5 BridgeHead Software Ltd. Recent Developments
  79. 8.14 PaxeraHealth
  80. 8.14.1 PaxeraHealth Company Information
  81. 8.14.2 PaxeraHealth Business Overview
  82. 8.14.3 PaxeraHealth Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (2021-2026)
  83. 8.14.4 PaxeraHealth Vendor Neutral Archive (VNA) & PACS Product Portfolio
  84. 8.14.5 PaxeraHealth Recent Developments
  85. 8.15 Medicasoft
  86. 8.15.1 Medicasoft Company Information
  87. 8.15.2 Medicasoft Business Overview
  88. 8.15.3 Medicasoft Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Medicasoft Vendor Neutral Archive (VNA) & PACS Product Portfolio
  90. 8.15.5 Medicasoft Recent Developments
  91. 8.16 Visus Health IT GmbH
  92. 8.16.1 Visus Health IT GmbH Company Information
  93. 8.16.2 Visus Health IT GmbH Business Overview
  94. 8.16.3 Visus Health IT GmbH Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Visus Health IT GmbH Vendor Neutral Archive (VNA) & PACS Product Portfolio
  96. 8.16.5 Visus Health IT GmbH Recent Developments
  97. 8.17 POSTDICOM
  98. 8.17.1 POSTDICOM Company Information
  99. 8.17.2 POSTDICOM Business Overview
  100. 8.17.3 POSTDICOM Vendor Neutral Archive (VNA) & PACS Revenue and Gross Margin (2021-2026)
  101. 8.17.4 POSTDICOM Vendor Neutral Archive (VNA) & PACS Product Portfolio
  102. 8.17.5 POSTDICOM Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst